A bidding war is brewing over $50 billion drugmaker Shire

Submitted by admin on April 19, 2018 - 10:17am

Source:

Business Insider

News Tags:

Headline:

snippet:

Shire rejected Takeda's $60 billion takeover bid on Thursday, and now Allergan's reportedly entering the bidding war.
The $60 billion bid was a 50% premium to Shire's stock price on March 27, the day before Takeda initially approached Shire.
Reuters reported Thursday that Allergan is also interested in acquiring Shire, creating a potential bidding war over the $50 billion drugmaker.

Search form